| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 3e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 0.0007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |